Advertisement
Screener

CHINA BCT PHARMACY GROUP, INC. Capital Expenditures

CHINA BCT PHARMACY GROUP, INC. Capital Expenditures

CHINA BCT PHARMACY GROUP, INC. reported Capital Expenditures of $1.55 million for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-20.

Discontinued › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2013-05-20

  • CHINA BCT PHARMACY GROUP, INC. payments to acquire property, plant, and equipment for the quarter ending 2013-03-31 was $1.55M, a 47.29% increase year-over-year.
  • CHINA BCT PHARMACY GROUP, INC. payments to acquire property, plant, and equipment for the quarter ending 2012-12-31 was $3.17M, a 45.07% increase year-over-year.
  • CHINA BCT PHARMACY GROUP, INC. payments to acquire property, plant, and equipment for the quarter ending 2012-09-30 was $478.11K, a 32.82% decline year-over-year.
  • CHINA BCT PHARMACY GROUP, INC. payments to acquire property, plant, and equipment for the quarter ending 2012-06-30 was $1.06M, a 8.44% decline year-over-year.
  • CHINA BCT PHARMACY GROUP, INC. payments to acquire property, plant, and equipment for fiscal 2012 was $5.76M, a 41.54% increase from fiscal 2011.
  • CHINA BCT PHARMACY GROUP, INC. payments to acquire property, plant, and equipment for fiscal 2011 was $4.07M, a 804.59% increase from fiscal 2010.
  • CHINA BCT PHARMACY GROUP, INC. payments to acquire property, plant, and equipment for fiscal 2010 was $450.11K.
Period endPayments to Acquire Property, Plant, and Equipment 3 monthPayments to Acquire Property, Plant, and Equipment 6 monthPayments to Acquire Property, Plant, and Equipment 9 monthPayments to Acquire Property, Plant, and Equipment 12 month
2013-03-31$1.55M
10-Q · filed 2013-05-20
$4.72M
derived: sum of 2 quarters · filed 2013-05-20
$5.20M
derived: sum of 3 quarters · filed 2013-05-20
$6.26M
derived: sum of 4 quarters · filed 2013-05-20
2012-12-31$3.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-15
$3.65M
derived: sum of 2 quarters · filed 2013-04-15
$4.71M
derived: sum of 3 quarters · filed 2013-04-15
$5.76M
10-K · filed 2013-04-15
2012-09-30$478.11K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-15
$1.54M
derived: sum of 2 quarters · filed 2012-11-15
$2.59M
10-Q · filed 2012-11-15
$4.78M
derived: sum of 4 quarters · filed 2013-05-20
2012-06-30$1.06M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-17
$2.12M
10-Q · filed 2012-08-17
$4.30M
derived: sum of 3 quarters · filed 2013-05-20
$5.01M
derived: sum of 4 quarters · filed 2013-05-20
2012-03-31$1.05M
10-Q · filed 2013-05-20
$3.24M
derived: sum of 2 quarters · filed 2013-05-20
$3.95M
derived: sum of 3 quarters · filed 2013-05-20
$5.11M
derived: sum of 4 quarters · filed 2013-05-20
2011-12-31$2.18M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-15
$2.90M
derived: sum of 2 quarters · filed 2013-04-15
$4.06M
derived: sum of 3 quarters · filed 2013-04-15
$4.07M
10-K · filed 2013-04-15
2011-09-30$711.73K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-15
$1.87M
derived: sum of 2 quarters · filed 2012-11-15
$1.89M
10-Q · filed 2012-11-15
$2.22M
derived: sum of 4 quarters · filed 2012-11-15
2011-06-30$1.16M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-17
$1.18M
10-Q · filed 2012-08-17
$1.51M
derived: sum of 3 quarters · filed 2012-08-17
$1.56M
derived: sum of 4 quarters · filed 2012-08-17
2011-03-31$15.04K
10-Q · filed 2012-05-21
$345.51K
derived: sum of 2 quarters · filed 2012-06-12
$394.97K
derived: sum of 3 quarters · filed 2012-06-12
2010-12-31$330.46K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-06-12
$379.92K
derived: sum of 2 quarters · filed 2012-06-12
$450.11K
10-K/A · filed 2012-06-12
2010-09-30$49.46K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14
$119.64K
10-Q · filed 2011-11-14
2010-06-30$70.18K
10-Q · filed 2011-08-15